Disclosure Of Analysis Of Other Comprehensive Income By Item [Text Block]

Innate Pharma - Filing #2813423

Concept	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Disclosure of analysis of other comprehensive income by item [text block]	—	—	Autres éléments du résultat global	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of analysis of other comprehensive income by item [abstract]
Disclosure of analysis of other comprehensive income by item [line items]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations	— EUR	428,000 EUR	428,000 EUR	— EUR	— EUR	— EUR	— EUR	— EUR	— EUR	—	— EUR	— EUR	— EUR	483,000 EUR	— EUR	483,000 EUR
Other comprehensive income, net of tax, financial assets measured at fair value through other comprehensive income	—	—	— EUR	—	—	—	—	—	—	—	—	—	—	—	—	— EUR
Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans	—	—	790,000 EUR	—	—	—	—	—	— EUR	— EUR	— EUR	— EUR	— EUR	584,000 EUR	— EUR	584,000 EUR